- Home
- SBS vs SNN Comparison
SBS vs SNN Comparison
Compare SBS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBS
- SNN
- Stock Information
- Founded
- SBS 1954
- SNN 1856
- Country
- SBS Brazil
- SNN United Kingdom
- Employees
- SBS N/A
- SNN N/A
- Industry
- SBS Water Supply
- SNN Industrial Specialties
- Sector
- SBS Utilities
- SNN Health Care
- Exchange
- SBS Nasdaq
- SNN Nasdaq
- Market Cap
- SBS 14.4B
- SNN 15.2B
- IPO Year
- SBS 2002
- SNN 1999
- Fundamental
- Price
- SBS $26.16
- SNN $33.34
- Analyst Decision
- SBS
- SNN Hold
- Analyst Count
- SBS 0
- SNN 4
- Target Price
- SBS N/A
- SNN $33.50
- AVG Volume (30 Days)
- SBS 860.0K
- SNN 664.9K
- Earning Date
- SBS 11-10-2025
- SNN 10-30-2025
- Dividend Yield
- SBS 2.13%
- SNN 2.19%
- EPS Growth
- SBS 174.82
- SNN 59.91
- EPS
- SBS 3.00
- SNN 0.56
- Revenue
- SBS $7,382,628,649.00
- SNN $5,944,000,000.00
- Revenue This Year
- SBS N/A
- SNN $7.85
- Revenue Next Year
- SBS $11.93
- SNN $5.43
- P/E Ratio
- SBS $8.56
- SNN $59.75
- Revenue Growth
- SBS 48.83
- SNN 5.35
- 52 Week Low
- SBS $13.87
- SNN $23.69
- 52 Week High
- SBS $26.08
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- SBS 74.45
- SNN 34.58
- Support Level
- SBS $25.35
- SNN $31.83
- Resistance Level
- SBS $25.88
- SNN $33.60
- Average True Range (ATR)
- SBS 0.41
- SNN 0.50
- MACD
- SBS 0.14
- SNN -0.38
- Stochastic Oscillator
- SBS 87.22
- SNN 28.90
About SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.